A novel diagnostic test using just a nasal swab could transform how doctors diagnose and treat childhood asthma. Researchers ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

but the new formulation will allow patients to take greater control of their treatment. Like its predecessor, it is approved in the EU for use in patients 12 years and older with severe asthma who ...

Bayer’s Nexavar and Boehringer Ingelheim's Spiriva are among a handful of drugs with reduced US list prices for the new year, ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

A noninvasive approach could help clinicians prescribe medications more precisely for patients according to endotype.

Allergies are a type of hypersensitivity reaction caused by the immune system. There are many types of allergies. You can be ...

Using nasal swabs to identify a child’s asthma subtype may lead to more precise medication prescribing and development of ...

Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives.

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...